MDDG and Moffitt Cancer Center Form Tampa Medical Innovations to Commercialize Inventions

February 3, 2012

Medical Device Development Group, specialists in the commercialization of medical devices, have announced a joint venture with Moffitt Cancer Center. The new organization, called Tampa Medical Innovations (TaMI), will commercialize medical device inventions envisioned by the Moffitt medical team.

The lead product is an IV closure system designed to eliminate blood loss during IV insertion and reduce the potential for blood-borne pathogen exposure. “The process of connecting intravenous fluid tubing to a catheter that has been inserted into a vein basically requires three hands,” explained Tariq Chaudhry, M.D., the inventive anesthesiologist at Moffitt. “The Stat-Clip system is a break-through technology that solves a long-standing issue in the practice of IV therapy by eliminating blood exposure between establishment of patency and connection of the IV line.”

There are approximately 176 million IV procedures performed annually in the United States, and each has the potential for cross contamination and blood-borne pathogen exposure, two key sources for infection.

“We are delighted to join with Medical Device Development Group to bring important new inventions to market,” said Haskell Adler, PhD MBA, Senior Licensing Manager at Moffitt. “We believe that this venture is the best way to accelerate commercialization and get these innovations into routine use worldwide.”

MDDG uses a proprietary project management framework called Strategic Parallel Implementation™ (SPI), a proven methodology that ensures each critical activity on the path to commercialization is successfully completed at the optimum time. The company has identified eight essential elements that are required to achieve commercialization success and provides these singly or as part of a turnkey SPI program: business planning, marketing, compliance, human factors, supply chain, technology, risk management and management of legal services.

“Some of the best innovations come from doctors and nurses whose daily patient care leads them to see a need and find a solution.” said Bill Knab, CEO of TaMI. “Our goal with TaMI is to transform these inventions into products that will improve patient care and simplify medical procedures.”

TaMI is currently seeking first-round funding to accelerate the development of the Stat-Clip system as well as other medical innovations from Moffitt.

About Moffitt Cancer Center
Located in Tampa, Moffitt Cancer Center is the only Florida-based National Cancer Institute Comprehensive Cancer Center, a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt has 14 affiliates in Florida, one in Georgia, one in Pennsylvania and two in Puerto Rico. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer.

About Medical Device Development Group
Medical Device Development Group (MDDG) was founded in 2006 by experienced medical device executives, each with more than 20 years in the industry. With a focus on devices in Class 1 to Class 3, MDDG offers comprehensive product development as well as skills that extend from product conceptualization, through prototyping and manufacturing, to order fulfillment. MDDG’s proprietary business methodologies and processes have been proven to reduce time to market and enhance profitability.

Despite Recession, Medical Device Development Group Continues to Thrive

July 14, 2011

Medical Device Development Group (MDDG) is celebrating its fifth anniversary, having not only survived the recession, but actually thrived. The company, which is focused on medical devices, provides comprehensive product development as well as resources that extend from product conceptualization, through prototyping and manufacturing, to order fulfillment.

“Recession? What recession?” says Partner Don White with a hearty laugh. “We’ve been consistently busy for the past few years working with a range of companies and projects. We’ve been lucky, but then I was told a long time ago that the harder you work, the luckier you get.”

The MDDG business model has two sides: 1) providing a full range of support for existing companies that are commercializing medical device products; and 2) discovering innovative technologies, establishing a company to commercialize the product and then spinning it off as a separate entity. MDDG clients range in size from international companies to independent inventors, start-ups, universities and nonprofit organizations.

Read more